Skip to main content
. 2016 Apr 20;39:589–611. doi: 10.1007/s40264-016-0420-2

Fig. 2.

Fig. 2

Overview of the pathophysiological changes in patients with liver cirrhosis that influence drug metabolism and therefore the pharmacokinetics of drugs. CYP cytochrome P450, UGT uridine diphosphate-glucuronosyltransferase, ↓ indicates decrease, ↑ indicates increase